508. Title Favipiravir for the Treatment of Coronavirus Disease 2019; A Propensity Score Matched Cohort Study

BACKGROUND: We investigated clinical outcomes of favipiravir in patients with COVID-19 pneumonia. METHODS: Patients who between 23 May 2020 and 18 July 2020 received ≥24 hours of favipiravir were assigned to the favipiravir group, while those who did not formed the non-favipiravir group. The primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Alattar, Rand A, Ahmed, Shiema A, Abdallah, Tasneem, Kazman, Rashid, Qadmour, Aseelah N, Ibrahim, Tawheeda, Alhariri, Bassem, Shaar, Shahd H, Bajwa, Abeer, Alimam, Abeir, Qazi, Rabia, Abid, Fatma Ben, Daghfal, Joanne, Eldeeb, Ali M, Shukri, Kinda, Elsayed, Ahmed, Rustom, Fatima, AlSamawi, Musaed S, Abdelmajid, Alaaeldin A, Basulto, Miguel, Cobian, Armando, Khattab, Mohammed Abu, Almaslamani, Muna, Khal, Abdullatif Al, Omrani, Ali S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644787/
http://dx.doi.org/10.1093/ofid/ofab466.707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644787/
http://dx.doi.org/10.1093/ofid/ofab466.707

Ejemplares similares